Content about Pharmacy

July 11, 2012

DSN talked to Cardinal Health SVP independent sales Steve Lawrence about the big news from Cardinal’s 2012 Retail Business Conference, including a best practices competition for its customers, its Women in Pharmacy program and Cardinal’s joint outreach program with the Ohio State University College of Pharmacy aimed at preventing prescription drug abuse.

AUDIO Q&A: DSN talked to Cardinal Health SVP independent sales Steve Lawrence about the big news from Cardinal’s 2012 Retail Business Conference, including a best practices competition for its customers, its Women in Pharmacy program and Cardinal’s joint outreach program with the Ohio State University College of Pharmacy aimed at preventing prescription drug abuse.

May 21, 2012

Retail pharmacy veteran Frank Scorpiniti officially assumed the role of CEO of Rexall Pharma Plus in February. Now that he’s settled in North of the Border, Scorpiniti talked with Drug Store News about his new role and his insights on the Canadian retail pharmacy market.

Retail pharmacy veteran Frank Scorpiniti officially assumed the role of CEO of Rexall Pharma Plus in February. Now that he’s settled in North of the Border, Scorpiniti talked with Drug Store News about his new role and his insights on the Canadian retail pharmacy market.

April 25, 2012

Careers in Pharmacy prepares students and prospective students for a career in pharmacy with articles on the latest career options, how to prepare for a pharmacy career, pharmacy practice in the new healthcare system and a list of U.S. pharmacy colleges, as well as profiles of day-to-day responsibilities of pharmacists in different sectors of the pharmacy industry.

Careers in Pharmacy prepares students and prospective students for a career in pharmacy with articles on the latest career options, how to prepare for a pharmacy career, pharmacy practice in the new healthcare system and a list of U.S. pharmacy colleges, as well as profiles of day-to-day responsibilities of pharmacists in different sectors of the pharmacy industry.

April 23, 2012

In part 3, VP health and wellness operations and compliance Jim Langman and director of business development Angie Muldoon discuss how Sam's Club's clinical offerings — pharmacy, optical and hearing aid centers — and its health screenings and new magazine align with the retailer's wellness platform.

In late January, DSN.TV traveled to Bentonville, Ark., for an exclusive look at what Sam's Club is doing to win in health and wellness. In part 3, VP health and wellness operations and compliance Jim Langman and director of business development Angie Muldoon discuss how Sam's Club's clinical offerings — pharmacy, optical and hearing aid centers — and its health screenings and new magazine align with the retailer's wellness platform.
 

March 27, 2012

In November 2011, The Drug Store News Group hosted in New York an exclusive roundtable discussion of leading pharmacy retailers and a handful of key vendors. Moderated by special guest Dave Wendland of Hamacher Resource Group, the panel tackled a wide range of issues surrounding diabetes management and much more.

In November 2011, The Drug Store News Group hosted in New York an exclusive roundtable discussion of leading pharmacy retailers and a handful of key vendors.

March 21, 2012

Earlier this month, Walgreens announced that immunization records would be sent directly from its more than 7,800 Walgreens and Duane Reade stores and 350 Take Care Clinics to primary care providers over Surescripts’ electronic prescribing network using Surescripts’ Clinical Interoperability services. And later this year, the company plans to share immunization data with local and state public health agencies, and share Take Care Clinic patient summaries with primary care providers. Drug Store News recently had the opportunity to speak with Surescripts president and CEO Harry Totonis about the new service.

AUDIO Q&A: DSN spoke with Harry Totonis, Surescripts president and CEO, about its new services. Earlier this month, Walgreens announced that immunization records would be sent directly from its more than 7,800 Walgreens and Duane Reade stores and 350 Take Care Clinics to primary care providers over Surescripts’ electronic prescribing network using Surescripts’ Clinical Interoperability services.

March 19, 2012

DSN's Pharmacy Technology Report takes a look at the hottest technology in the health-and-wellness space and where investors are looking to take health IT in the future. Also included is DSN's exclusive roundtable discussion with leading pharmacy retailers and executives from leading and emerging healthcare technology companies, which included new technologies to improve compliance, self-care and pharmacist-patient interactions.

DSN's Pharmacy Technology Report takes a look at the hottest technology in the health-and-wellness space and where investors are looking to take health IT in the future. Also included is DSN's exclusive roundtable discussion with leading pharmacy retailers and executives from leading and emerging healthcare technology companies, which included new technologies to improve compliance, self-care and pharmacist-patient interactions.

March 5, 2012

Radio Health Journal's Reed Pence talks with DSN editor in chief Rob Eder; Walgreens president of pharmacy, health and wellness Kermit Crawford; Express Scripts senior director of public affairs Brian Henry; and former Walgreens pharmacy customer Virginia Greathouse about the causes and impact of the Walgreens-ESI dispute.

Radio Health Journal's Reed Pence talks with DSN editor in chief Rob Eder; Walgreens president of pharmacy, health and wellness Kermit Crawford; Express Scripts senior director of public affairs Brian Henry; and former Walgreens pharmacy customer Virginia Greathouse about the causes and impact of the Walgreens-ESI dispute.

February 28, 2012

Walgreens Specialty Pharmacy in late February released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites, such as the ones fielded by Walgreens. DSN caught up with Michael Einodshofer, director of utilization management at Walgreens Specialty Pharmacy, to discuss the potential cost-reduction impact savings it can have on employers and payers.

AUDIO Q&A: Walgreens Specialty Pharmacy in late February released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites, such as the ones fielded by Walgreens.

February 28, 2012

As part of its Executive Retailer Viewpoint series, DSN sat down with Chuck Wilson, VP pharmacy operations at Health Mart, at DSN's Industry Issues Summit to discuss opportunities for community pharmacy to improve patient outcomes.

As part of its Executive Retailer Viewpoint series, DSN sat down with Chuck Wilson, VP pharmacy operations at Health Mart, at DSN's Industry Issues Summit to discuss opportunities for community pharmacy to improve patient outcomes.

February 27, 2012

Community pharmacy brings innovation to patient care

One of America’s most intractable challenges is the staggering cost of health care. Policy-makers agree that Medicare and Medicaid — not to mention the nation’s frayed health system overall — can’t continue to sustain the costs of care. One vital but underutilized resource that could help break the cost cycle is the nation’s 56,000 community pharmacies — and the pharmacists who staff them.

February 23, 2012

In November 2011, The Drug Store News Group/Specialty Pharmacy magazine hosted in New York an exclusive executive round-table discussion of leading specialty pharmacy providers. Guest moderator and veteran pharmacy executive Dave Fong and the panel examined a range of topics, including channel management strategies, accountable care organizations and the importance of technology.

Click below to download the complete PDF of the 2011 Specialty Pharmacy Roundtable.

February 17, 2012

As part of its Executive Retailer Viewpoint series, DSN sat down with Mike Cantrell, president at Good Neighbor Pharmacies, at DSN's Industry Issues Summit to discuss technology and the evolution of pharmacy care.

As part of its Executive Retailer Viewpoint series, DSN sat down with Mike Cantrell, president at Good Neighbor Pharmacies, at DSN's Industry Issues Summit to discuss technology and the evolution of pharmacy care.

February 1, 2012

As part of DSN's Executive Retailer Viewpoint series, DSN sat down with Jason Reiser, VP health and wellness, ops/compliance at Sam's Club, at DSN's Industry Issues Summit to discuss how to better engage customers and the impact of the economy on business in 2012.

As part of DSN's Executive Retailer Viewpoint series, DSN sat down with Jason Reiser, VP health and wellness, ops/compliance at Sam's Club, at DSN's Industry Issues Summit to discuss how to better engage customers and the impact of the economy on business in 2012.

January 18, 2012

In an effort to tap into the minds of some of the industry's top executives, Drug Store News recently sat down and talked with some of these leaders in a multipart executive viewpoint video series.

In an effort to tap into the minds of some of the industry's top executives, Drug Store News recently sat down and talked with some of these leaders in a multipart executive viewpoint video series.

This powerful series, sponsored by Pfizer, is comprised of five different on-camera executive interviews that are a must see for anyone working within the retail pharmacy industry.

January 3, 2012

On Sunday, Jan. 1, Walgreens' contract with Express Scripts expired, and millions of Walgreens customers covered by ESI were forced to either move their pharmacy business to another pharmacy in the Express Script network or come up with some other way to stick with Walgreens. DSN editor Rob Eder on Tuesday interviewed Walgreens president and CEO Greg Wasson on what the company is doing to hold on to those customers and to appeal to payers, and what the potential ESI-Medco deal could mean.

AUDIO Q&A: On Sunday, Jan. 1, Walgreens' contract with Express Scripts expired, and millions of Walgreens customers covered by ESI were forced to either move their pharmacy business to another pharmacy in the Express Script network or come up with some other way to stick with Walgreens.

October 11, 2011

CVS Caremark has grown from a go-getting New England-based regional player to a nearly $100 billion pharmacy healthcare giant known for its vertically integrated pharmacy-PBM model via the 2007 acquisition of Caremark, its highly successful loyalty card program and its innovative beauty concepts. Now, the industry trailblazer embarks on a new chapter with a new leader and an eye on driving medication adherence, curbing healthcare costs and improving the health outcomes of its patients.

Over the years, CVS Caremark has grown from a go-getting New England-based regional player to a nearly $100 billion pharmacy healthcare giant known for its vertically integrated pharmacy-PBM model via the 2007 acquisition of Caremark, its highly successful loyalty card program and its innovative beauty concepts.

August 24, 2011

Behind every prescription that lands at the pharmacy counter is a series of events that influence the prescriber’s decision. Powered by data from SDI Health, Drug Store News goes inside the examination room in this exclusive report, providing an in-depth look at the critical factors that shape pharmaceutical sales trends and shift market share from one drug to another in 10 key market segments.

Behind every prescription that lands at the pharmacy counter is a series of events that influence the prescriber’s decision. Powered by data from SDI Health, Drug Store News goes inside the examination room in this exclusive report, providing an in-depth look at the critical factors that shape pharmaceutical sales trends and shift market share from one drug to another in 10 key market segments.

Click below to download the complete PDF of the 2011 Annual Prescriber Report.

April 25, 2011

85% — that’s more or less the combined market share for the companies that make up the 2011 DSN PoweRx50, approximately $185 billion of the total $218 billion retail pharmacy industry. The DSN PoweRx50 indisputably reflects the true titans of the retail pharmacy industry. It is the ONLY truly CHANNEL-AGNOSTIC ranking of the retail pharmacy industry that measures all of retail pharmacy, including traditional drug chains, independents, supermarkets, mass and club stores — ALL of it. BA-BOOM!

85% — POW! — that’s more or less the combined market share for the companies that make up the 2011 DSN PoweRx50, approximately $185 billion of the total $218 billion retail pharmacy industry. Numbering almost 50,000 stores among them, or more than 8-of-10 of all the pharmacies in the United States — BAM! — the DSN PoweRx50 indisputably reflects the true titans of the retail pharmacy industry.

March 25, 2011

There are a million stories in the retail pharmacy industry — this is about a dozen of them. Early in 2011, the editors and publishers of Drug Store News put out a call to select members of the vendor community for a chance to tell the stories of their companies, in their own words. What followed is DSN’s first-ever user-generated special report.

There are a million stories in the retail pharmacy industry — this is about a dozen of them. Early in 2011, the editors and publishers of Drug Store News put out a call to select members of the vendor community for a chance to tell the stories of their companies, in their own words. What followed is DSN’s first-ever user-generated special report. For information on how your company might participate in future user-generated reports, contact Rob Eder, editor-in-chief of The Drug Store News Group at reder@lf.com.

February 18, 2011

Talk about a bold retail vision. Walgreens president and CEO Greg Wasson said the nation’s top pharmacy retailer wants nothing less than to “own well.” He’s serious. Owning “well” — or, put another way, becoming the nation’s top retail resource for pharmacy and health-and-wellness services and products — is the kind of declaration few retail pharmacy executives would dare utter. But Wasson isn’t running just any drug store chain.

Talk about a bold retail vision. Walgreens president and CEO Greg Wasson said the nation’s top pharmacy retailer wants nothing less than to “own well.” He’s serious. Owning “well” — or, put another way, becoming the nation’s top retail resource for pharmacy and health-and-wellness services and products — is the kind of declaration few retail pharmacy executives would dare utter. But Wasson isn’t running just any drug store chain.

April 16, 2014

Dr. Reddy's Labs announced the launch of eszopiclone tablets (C-IV) in 1-mg, 2-mg and 3-mg form. The drug is the generic version of Lunesta (eszopiclone) tablets.

HYDERABAD, India — Dr. Reddy's Labs announced the launch of eszopiclone tablets (C-IV) in 1-mg, 2-mg and 3-mg form. The drug is the generic version of Lunesta (eszopiclone) tablets.

The Lunesta tablets brand and generic combined had sales in the United States of approximately $887 million for the most recent twelve months ending in January 2014, according to IMS Health. Dr. Reddy's eszopiclone tablets 1-mg is available in bottle counts of 30; 2-mg and 3-mg tablets are available in bottle counts of 100.

April 16, 2014

With less than five months until the doors open for the second National Association of Chain Drug Stores' Total Store Expo, the association announced its line-up of educational “Insight Sessions,” which will offer presentations by experts on a variety of key issues and priorities, including healthcare, business and logistics.

ARLINGTON, Va. — With less than five months until the doors open for the second National Association of Chain Drug Stores' Total Store Expo, the association announced its line-up of educational “Insight Sessions,” which will offer presentations by experts on a variety of key issues and priorities including healthcare, business and logistics.

The NACDS Total Store Expo will take place Aug. 23 to 26 at the Boston Convention & Exhibition Center in Boston.

April 16, 2014

Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research released Tuesday from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge.

BALTIMORE — Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research released Tuesday from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge. The researchers also found that the burden of the disease has not hit all groups equally, with alarming increases in diabetes in blacks, Hispanics and the elderly.

April 15, 2014

Actavis on Tuesday announced that it has entered into an agreement with Mylan and Famy Care to settle all outstanding patent litigation related to Mylan's generic version of Generess FE (norethindrone, ethinyl estradiol and ferrous fumarate chewable tablets).

DUBLIN — Actavis on Tuesday announced that it has entered into an agreement with Mylan and Famy Care to settle all outstanding patent litigation related to Mylan's generic version of Generess FE (norethindrone, ethinyl estradiol and ferrous fumarate chewable tablets).

Under the terms of the agreement, Actavis will grant Mylan a license to market its generic version of Generess FE under its pending abbreviated new drug application beginning on April 1, 2015.